Global Embryonic Stem Cell Market Trends
Embryonic Stem Cells Market Insights The global embryonic stem cells market is estimated to grow at a significant CAGR during the forecast period. The key driver for growth in the embryonic stem cells market is increasing government funding for the development of regenerative medicines in most developed countries. Growing applications of embryonic stem cells in the organ transplantation, tissue engineering, and various other applications are further expected to propel the embryonic stem cells market. Rising demand for regenerative medicine is also propelling the growth of the embryonic stem cells market. Increasing R&D activities, investments and research initiatives across the globe by key manufactures of stem cell are some of the major factors expected to propel the market during the forecast period. Increasing support from government and private institutions, along with increasing prevalence of genetic disorders are driving the human embryonic stem cells market. However, Expensive procedures and regulatory complications are some of the major factors expect expected to hinder the growth of embryonic stem cells market. Request a sample copy of the report @ https://www.globalmarketestimates.com/global-embryonic-stem-cells-market/ Embryonic Stem Cells Market: Vendor Landscape This report contains a chapter dedicated, to vendors operating in the market, report covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides insights on a regional level vendors and manufactures. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Embryonic Stem Cells Market: End-Use Landscape The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the market are CellGenix GmbH, PromoCell GmbH, Kite Pharma and Angel Biotechnology among others. Embryonic Stem Cells Market Key Players: Key players in the market include Australian Stem Cell Centre, BD Biosciences, Cellartis AB, Geron Corporation Invitrogen Corporation, Millipore Corporation, SA Biosciences Corporation, Tataa Biocenter, Thermo Scientific, Viacyte, Vitrolife AB, and Advanced Cell Technology Inc among others. In December 2017: Viacyte Inc. was approved a grant by the California Institute for Regenerative Medicine (CIRM), for the initial development of immune-evasive pluripotent stem cell lines In 2018, Novartis received EU approval for its CAR-T cell therapy, Kymriah Browse the report @ https://www.globalmarketestimates.com/global-embryonic-stem-cells-market/
★
★
★
★
★
34 views • 3 slides
